Betaserc
product
Expand all ↓

This medicine is marketed under various brand names, including Serc® and Vertin®.
Brand names may vary by country. This information refers to the product as marketed in selected countries.

Betahistine dihydrochloride (International Nonproprietary Name: Betahistine)

This medicine is available in several forms:
• Film-coated tablets (8 mg, 16 mg, 24 mg)
• Orodispersible tablets (24 mg)
• Modified-release tablets (48 mg)
Available forms may vary by country. Please consult your local label.

Oral use

This medicine is used to manage:
• Ménière’s disease, which includes symptoms such as vertigo (often with nausea or vomiting), hearing loss, and tinnitus.
• Symptomatic treatment of vestibular vertigo (a condition that causes dizziness and balance issues).
Approved uses may differ by country. Always refer to the locally approved product information.

This medicine is used to manage:
• Ménière’s disease, which includes symptoms such as vertigo (often with nausea or vomiting), hearing loss, and tinnitus.
• Symptomatic treatment of vestibular vertigo (a condition that causes dizziness and balance issues).
Approved uses may differ by country. Always refer to the locally approved product information.

Betahistine works by influencing certain natural chemicals in the body, particularly histamine. It helps improve blood flow in the inner ear and supports the brain’s balance system. This may help reduce the frequency and severity of dizziness and other symptoms related to balance disorders.

Anti-vertigo medicine

This page is intended for general informational purposes only and does not replace professional medical advice. Product availability, indications, and labelling may vary by country. Like all drugs, this medicine may cause side effects. Talk to your doctor if you experience any unusual symptoms. Always consult your healthcare provider and refer to the locally approved product information.